10 questions about using apomorphine for Parkinson disease.
Dewey
Richard B
RB
University of Texas Southwestern Medical Center, Dallas, TX 75390-9036, USA. Richard.Dewey@UTSouthwestern.edu
D000932:Antiemetics / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001058:Apomorphine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D010300:Parkinson Disease / Q000188:drug therapy* / Q000601:surgery; D012008:Recurrence; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control
D000932:Antiemetics; D000978:Antiparkinson Agents; D001549:Benzamides; D001058:Apomorphine; C100146:trimethobenzamide